Blood pressure is increased in a patient having a condition which effects rapid firing of neurons in the sympathetic nervous system and low blood pressure by administering tyrosine to the patient. The tyrosine composition can be administered alone or concomitantly with a drug which increases noradrenergic neurotransmission in the sympathetic nervous system.
REFERENCE TO RELATED APPLICATION
This is a continuation of application Ser. No. 366,887 filed on Apr. 8, 1982, now abandoned, which is a division of application Ser. No. 145,909, now U.S. Pat. No. 4,327,112, issued 4-27-82, which is a continuation-in-part of application Ser. No. 088,226, filed Oct. 10, 25, 1979, now abandoned which in turn is a continuation of Ser. No. 898,740, filed Apr. 27, 1978, now abandoned.
A combination therapy for the treatment of heart failure, particularly acute heart failure, comprises administering a combination of levosimendan or a pharmaceutically acceptable salt thereof and a calcium ion source and/or an intracellular calcium increasing agent to a patient. The combination shows a synergistic effect even at doses having no effect if administered alone.
